High dose 1, 25(OH) 2D 3 inhibits osteoblast mineralization in vitro

International Journal of Molecular Medicine

Volumn 29, Issue 5, 2012, Pages 934-938

  Yamaguchi, Masayoshi ^a   Weitzmann, M Neale ^a,b  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b ATLANTA VA MEDICAL CENTER   (United States)

Author keywords

Nuclear factor B; Osteoblast; Osteoporosis; Smad; Vitamin D

Indexed keywords

BONE MORPHOGENETIC PROTEIN 2; CALCITRIOL; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL CELL; ARTICLE; BONE MASS; BONE MINERALIZATION; CALCIUM ABSORPTION; CELL DIFFERENTIATION; CELL FUNCTION; ENZYME ACTIVATION; IN VITRO STUDY; MOUSE; NONHUMAN; OSTEOBLAST; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

3T3 CELLS; ANIMALS; BONE DENSITY CONSERVATION AGENTS; BONE MORPHOGENETIC PROTEIN 2; CALCIFICATION, PHYSIOLOGIC; CALCITRIOL; CELLS, CULTURED; MICE; NF-KAPPA B; OSTEOBLASTS; SMAD PROTEINS; TRANSFORMING GROWTH FACTOR BETA;

EID: 84858256963     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm.2012.900     Document Type: Article

References (27)

1. Adams JS and Hewison M: Update in vitamin D. J Clin Endocrinol Metab 95: 471-478, 2010.
2. Bikle DD: Vitamin D: newly discovered actions require reconsideration of physiologic requirements. Trends Endocrinol Metab 21: 375-384, 2010.
3. Khazai N, Judd SE and Tangpricha V: Calcium and vitamin D: skeletal and extraskeletal health. Curr Rheumatol Rep 10: 110-117, 2008.
4. Yamaguchi M and Weitzmann MN: The bone anabolic carotenoid β-cryptoxanthin enhances transforming growth factor-β1-induced SMAD activation in MC3T3 preosteoblasts. Int J Mol Med 24: 671-675, 2009.
5. Li Y, Li A, Strait K, Zhang H, Nanes MS and Weitzmann MN: endogenous TNFalpha lowers maximum peak bone mass and inhibits osteoblastic Smad activation, through NF-kappaB. J Bone Miner Res 22: 646-655, 2007. (Pubitemid 351339092)
6. Sugimoto E and Yamaguchi M: Anabolic effect of genistein in osteoblastic MC3T3-E1 cells. Int J Mol Med 5: 515-520, 2000.
7. Yamaguchi M and Weitzmann MN: Vitamin K2 stimulates osteoblastogenesis and suppresses osteoclastogenesis by suppressing NF-κB activation. Int J Mol Med 27: 3-14, 2011.
8. Andrews NC and Faller DV: A rapid micropreparation technique for extraction of DNA-binding proteins from limiting numbers of mammalian cells. Nucleic Acids Res 19: 2499, 1991.
9. Yamaguchi M and Weitzmann MN: Zinc stimulates osteoblastogenesis and suppresses osteoclastogenesis by antagonizing NF-kappaB activation. Mol Cell Biochem 355: 179-186, 2011.
10. Yamaguchi M and Weitzmann MN: Quercetin, a potent suppressor of NF-κB and Smad activation in osteoblasts. Int J Mol Med 28: 521-525, 2011.
11. Yamaguchi M and Weitzmann MN: The bone anabolic carotenoids p-hydroxycinnamic acid and β-cryptoxanthin antagonize NF-kappaB activation in MC3T3 preosteoblasts. Mol Med Rep 2: 641-644, 2009.
12. Yamaguchi M and Weitzmann MN: The estrogen 17β-estradiol and phytoestrogen genistein mediate differential effects on osteoblastic NF-κB activity. Int J Mol Med 23: 297-301, 2009.
13. Guo R, Yamashita M, Zhang Q, et al: Ubiquitin ligase Smurf1 mediates tumor necrosis factor-induced systemic bone loss by promoting proteasomal degradation of bone morphogenetic signaling proteins. J Biol Chem 283: 23084-23092, 2008.
14. Yamazaki M, Fukushima H, Shin M, et al: Tumor necrosis factor alpha represses bone morphogenetic protein (BMP) signaling by interfering with the DNA binding of Smads through the activation of NF-kappaB. J Biol Chem 284: 35987-35995, 2009.
15. Chang J, Wang Z, Tang E, et al: Inhibition of osteoblastic bone formation by nuclear factor-kappaB. Nat Med 15: 682-689, 2009.
16. Wahl EC, Aronson J, Liu L, et al: Restoration of regenerative osteoblastogenesis in aged mice: modulation of TNF. J Bone Miner Res 25: 114-123, 2010.
17. Alles N, Soysa NS, Hayashi J, et al: Suppression of NF-kappaB increases bone formation and ameliorates osteopenia in ovariectomized mice. Endocrinology 151: 4626-4634, 2010.
18. Nanes MS: Tumor necrosis factor-alpha: molecular and cellular mechanisms in skeletal pathology. Gene 321: 1-15, 2003.
19. Eliseev RA, Schwarz EM, Zuscik MJ, O'Keefe RJ, Drissi H and Rosier RN: Smad7 mediates inhibition of Saos2 osteosarcoma cell differentiation by NFkappaB. Exp Cell Res 312: 40-50, 2006. (Pubitemid 41668590)
20. Janssens K, Ten Dijke P, Janssens S and Van Hul W: Transforming growth factor-beta1 to the bone. Endocr Rev 26: 743-774, 2005.
21. Tang Y, Wu X, Lei W, et al: TGF-beta1-induced migration of bone mesenchymal stem cells couples bone resorption with formation. Nat Med 15: 757-765, 2009.
22. Zhang F, Qiu T, Wu X, et al: Sustained BMP signaling in osteoblasts stimulates bone formation by promoting angiogenesis and osteoblast differentiation. J Bone Miner Res 24: 1224-1233, 2009.
23. Bischoff-Ferrari HA, Willett WC, Wong JB, et al: Prevention of nonvertebral fractures with oral vitamin D and dose dependency: a meta-analysis of randomized controlled trials. Arch Intern Med 169: 551-561, 2009.
24. Bjorkman M, Sorva A, Risteli J and Tilvis R: Vitamin D supplementation has minor effects on parathyroid hormone and bone turnover markers in vitamin D-deficient bedridden older patients. Age Ageing 37: 25-31, 2008. (Pubitemid 351146972)
25. Viljakainen HT, Vaisanen M, Kemi V, et al: Wintertime vitamin D supplementation inhibits seasonal variation of calcitropic hormones and maintains bone turnover in healthy men. J Bone Miner Res 24: 346-352, 2009.
26. von Hurst PR, Stonehouse W, Kruger MC and Coad J: Vitamin D supplementation suppresses age-induced bone turnover in older women who are vitamin D deficient. J Steroid Biochem Mol Biol 121: 293-296, 2010.
27. Ueno Y, Shinki T, Nagai Y, Murayama H, Fujii K and Suda T: In vivo administration of 1,25-dihydroxyvitamin D3 suppresses the expression of RANKL mRNA in bone of thyroparathyroid-ectomized rats constantly infused with PTH. J Cell Biochem 90: 267-277, 2003. (Pubitemid 37222195)